EU Exclusivity Review: Commission To Assess Impact On 'Skyrocketing' Drug Prices

Analysis will consider effect of incentives such as data exclusivity and supplementary protection certificates on drug prices, availability and access to medicines; European health ministers also pledge cooperation rein in what they see as the very high prices of some medicines.